When will Beam Therapeutics submit a BLA for Risto-cel?

Prediction market on kalshi. If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.

Liquidity: $501.25. Resolves: 4/8/2027.